Notice: This company has been marked as potentially delisted and may not be actively trading. TF Financial (THRD) Stock Forecast & Price Target Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrends Get the Latest News and Ratings for THRD and Related Stocks Enter your email address to receive the latest news and analysts' ratings for TF Financial and its competitors. Enter your email to sign up for newsletter Sign Up THRD Analyst Ratings Over TimeTypeCurrent Forecast12/5/23 to 12/4/241 Month Ago11/5/23 to 11/4/243 Months Ago9/6/23 to 9/5/241 Year Ago12/5/22 to 12/5/23Strong Buy0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)Buy3 Buy rating(s)3 Buy rating(s)3 Buy rating(s)0 Buy rating(s)Hold0 Hold rating(s)0 Hold rating(s)0 Hold rating(s)3 Hold rating(s)Sell0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)Consensus Price Target$20.33$20.33$20.33$5.30Forecasted Upside82.69% Upside41.89% Upside70.58% Upside-43.80% DownsideConsensus RatingBuyBuyBuyHold The Biggest Financial Event of 2024? (Ad)Should you buy, sell, or hold your stock? To find the answer, let’s look at the actions of the world’s wealthiest investors… Right now, the world’s wealthiest investors are preparing for what could become ‘the biggest financial event’ of 2024.Click here for the step-by-step details THRD Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History THRD Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table TF Financial Stock vs. The CompetitionTypeTF FinancialMedical CompaniesS&P 500Consensus Rating Score 3.00 2.81 2.50Consensus RatingBuyModerate BuyModerate BuyPredicted Upside82.69% Upside26,615.84% Upside7.23% UpsideNews Sentiment RatingNeutral NewsSee Recent THRD NewsPositive NewsPositive News Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export to Excel DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails8/9/2024Morgan Stanley3 of 5 stars UpgradeEqual Weight ➝ Overweight$12.00 ➝ $20.00+84.16%6/18/2024Stifel Nicolaus4 of 5 stars Initiated CoverageBuy$23.00+77.61%6/7/2024Raymond James4 of 5 stars Initiated CoverageOutperform$18.00+29.96%12/16/2022Jefferies Financial GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating DowngradeBuy ➝ Hold$30.00 ➝ $3.60-16.28%12/15/2022Lifesci CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingS. SlutskySubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeOutperform ➝ Market PerformAnalyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 03:20 AM ET. THRD Forecast - Frequently Asked Questions What is TF Financial's forecast for 2025? According to the research reports of 3 Wall Street equities research analysts, the average twelve-month stock price forecast for TF Financial is $20.33, with a high forecast of $23.00 and a low forecast of $18.00. Should I buy or sell TF Financial stock right now? 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for TF Financial in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" THRD shares. Does TF Financial's stock price have much upside? According to analysts, TF Financial's stock has a predicted upside of 82.69% based on their 12-month stock forecasts. Do Wall Street analysts like TF Financial more than its competitors? Analysts like TF Financial more than other "medical" companies. The consensus rating for TF Financial is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how THRD compares to other companies. Stock Forecasts and Research Tools Related Companies Centessa Pharmaceuticals Stock Forecast Akero Therapeutics Stock Forecast Mirum Pharmaceuticals Stock Forecast Amphastar Pharmaceuticals Stock Forecast Janux Therapeutics Stock Forecast Supernus Pharmaceuticals Stock Forecast Harmony Biosciences Stock Forecast Belite Bio Stock Forecast Structure Therapeutics Stock Forecast Disc Medicine Stock Forecast Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top Rated Stocks Top Rated Stocks Top Rated Dividend Stocks Top Rated Small-Cap Stocks Top Rated Tech Stocks Most Upgraded Stocks Most Downgraded Stocks Lowest Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter The Biggest Financial Event of 2024? (Ad)Should you buy, sell, or hold your stock? To find the answer, let’s look at the actions of the world’s wealthiest investors… Right now, the world’s wealthiest investors are preparing for what could become ‘the biggest financial event’ of 2024.Click here for the step-by-step details This page (NASDAQ:THRD) was last updated on 12/4/2024 by MarketBeat.com Staff From Our PartnersElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredLock in this share price before 12/5When the team that built Zillow into a $16B real estate leader launches a new company, it’s worth paying atten...Pacaso | SponsoredThe Crypto Secret Wall Street Doesn’t Want You to KnowThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredHas World War III already started?As global tensions are rising, so does the potential of direct conflict between the US and China. That's wh...Behind the Markets | SponsoredMeet the NYSE traded company behind a potentially blockbuster antiviral drugThis public company’s one lead drug alone, NV-387, potentially addresses a $2.5 to $4.3 billion market Imag...Smallcaps Daily | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TF Financial Corp Please log in to your account or sign up in order to add this asset to your watchlist. Share TF Financial With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
